Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL723257 | 0.87 | SLC7A5 (0.39) | SLC7A5 | |
| Valine SCHEMBL4409191 | 0.83 | SLC7A5 (0.52) | SLC7A5 | |
| SCHEMBL135879 | 0.80 | SLC7A5 (0.41) | SLC7A5 | |
| SCHEMBL1537267 | 0.80 | SLC7A5 (0.41) | SLC7A5 | |
| SCHEMBL9716065 | 0.79 | NOS3 (0.32) | SLC7A5 | |
| SCHEMBL9716084 | 0.79 | NOS3 (0.32) | SLC7A5 | |
| Serine SCHEMBL10612187 | 0.78 | SLC7A5 (0.45) | SLC7A5 | |
| SCHEMBL5704260 | 0.77 | NOS3 (0.36) | SLC7A5 | |
| SCHEMBL10530419 | 0.77 | SLC7A5 (0.52) | SLC7A5 | |
| SCHEMBL288204 | 0.77 | SLC7A5 (0.52) | SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2042601-A1 | Novel variant EGIII-like cellulase compositions | Genencor International, Inc. (US) | 2009-04-01 | — | — | EP | disclosed |
| EP-1305431-A2 | MUTANT TRICHODERMA REESEI EGIII CELLULASES, DNA ENCODING SUCH EGIII COMPOSITIONS AND METHODS FOR OBTAINING SAME | GENENCOR INTERNATIONAL, INC. (US) | 2003-05-02 | — | — | EP | disclosed |
| WO-2002012464-A2 | MUTANT TRICHODERMA REESEI EGIII CELLULASES DNA ENCODING SUCH EGIII COMPOSITIONS AND METHODS FOR OBTAINING SAME | GENENCOR INTERNATIONAL, INC. (US) | 2002-02-14 | — | — | WO | disclosed |